Fundraising Fox

Reshape Medical

San Clemente, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

JL
John Lehmann, M.D.Director
CT
Casey TanseyDirector
JD
Jeani DelagardelleDirector
KC
Kenneth CharhutDirector
RT
Richard ThompsonExecutive Officer, Director
BF
Bruce FeuchterExecutive Officer
DM
David MilneDirector

Investors · 2

Reported raises · per SEC filings

Form D private placements
$11MraisedFeb 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric MilledgeDirector
  • David MilneDirector
  • Bruce FeuchterExecutive Officer
  • John Lehmann, M.D.Director
  • Casey TanseyDirector
  • Kenneth CharhutDirector
  • Michael ManganoExecutive Officer, Director
  • Jeani DelagardelleDirector
  • Michael MashaalDirector
Offering amount
$11M
Amount sold
$11M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$38MraisedSep 2015 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeani DelagardelleDirector
  • Michael MashaalDirector
  • Kenneth CharhutDirector
  • Casey TanseyDirector
  • Bruce FeuchterExecutive Officer
  • Eric MilledgeDirector
  • David MilneDirector
  • John Lehmann, M.D.Director
  • Richard ThompsonExecutive Officer, Director
Offering amount
$38M
Amount sold
$38M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.8MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John Lehmann, M.D.Director
  • Casey TanseyDirector
  • Jeani DelagardelleDirector
  • Kenneth CharhutDirector
  • Richard ThompsonExecutive Officer, Director
  • Bruce FeuchterExecutive Officer
  • David MilneDirector
Offering amount
$8.8M
Amount sold
$8.8M
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.